01People & AIThe Pharmaceutical Workforce in the Age of AI
BOARD PAPER · OCTOBER 2026 ↗9 minute read · Crownbridge Group
A board agenda for capability, human judgement and accountable adoption across the medicines lifecycle.
Read online ↗GOVERNANCE · WORKFORCE · CONTROLADVISORY · CAPITAL · LAW
Private enquiryCrownbridge Group · The life sciences collection
Insights &
Perspectives.
Serious thinking for consequential decisions.
Independent analysis on the people, governance and strategic risks shaping pharmaceutical enterprise.
Explore the papers ↓The Pharmaceutical Workforce in the Age of AI
A board agenda for capability, human judgement and accountable adoption across the medicines lifecycle.
Read the paper ↗THE PHARMACEUTICAL BOARD AGENDAPeopleGovernanceTransactionsMedicines security
The pharmaceutical collection · October 2026
Four papers.
One integrated view.
Read the full text online, keep a PDF for your board pack, or share a perspective with your team.
4 papers
01People & AI02Governance & GrowthFrom Scientific Promise to Operational Readiness
BOARD PAPER · OCTOBER 2026 ↗9 minute read · Crownbridge Group
The leadership, workforce and governance foundations emerging life sciences companies need to scale.
Read online ↗03Transactions & PeoplePharmaceutical Acquisitions: The People and Governance Risks Behind the Deal
BOARD PAPER · OCTOBER 2026 ↗9 minute read · Crownbridge Group
A practical due diligence and integration agenda for protecting capability, accountability and continuity.
Read online ↗04Medicines SecurityMedicines Security in the Boardroom
BOARD PAPER · OCTOBER 2026 ↗9 minute read · Crownbridge Group
Connecting supply dependencies, pharmaceutical geopolitics and workforce resilience to accountable executive action.
Read online ↗Practical perspectives
Questions leaders are asking.
Focused articles that turn board priorities into practical next steps.
When Should a Life Sciences Company Appoint Its First CHRO?
Make the appointment against organisational complexity and the next growth milestone, rather than headcount alone.
Read online ↗ · Download PDF ↓Preparing a Biotech for Investment: The Operating Evidence Investors Need
Connect scientific milestones to accountable leadership, credible capability and transparent assumptions.
Read online ↗ · Download PDF ↓Retaining Critical Scientific Talent Without Creating Fragile Dependencies
Protect expertise, professional confidence and continuity together.
Read online ↗ · Download PDF ↓Restructuring a Pharmaceutical Organisation Without Weakening Control
Test proposed savings against workload, competence, authority and continuity.
Read online ↗ · Download PDF ↓Executive Succession in Life Sciences: Beyond a List of Names
Build readiness for the decisions a future leader will need to carry.
Read online ↗ · Download PDF ↓Editorial approach
Evidence. Judgement.
Action.
Our papers connect public evidence to practical questions for boards and executive teams. Each includes an executive summary, a proposed leadership agenda and linked sources.
These are advisory perspectives, not empirical research or peer-reviewed studies. Recommendations and illustrative scenarios are identified as such. Sources were checked for this edition on 14 October 2026.
Commission a focused board briefing ↗From the archive